VENROCK MANAGEMENT LLC 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Apr 12, 2004
Insider Transaction Report
Form 4Exit
VENROCK MANAGEMENT LLC
10% Owner
Transactions
- Conversion
Common Stock
[F1][F2]2004-04-08+14,233→ 14,233 total(indirect: By Fund) - Conversion
Series C Convertible Preferred Stock
[F3][F4][F2]2004-04-08−40,000→ 0 total(indirect: By Fund)→ Common Stock (14,233 underlying)
Footnotes (4)
- [F1]The shares of each Series of Preferred Stock were convertible into the number of shares of Common Stock indicated, and upon the closing of the Issuer's initial public offering of Common Stock, all such shares of Preferred Stock were automatically converted into the number of shares of Common Stock indicated.
- [F2]Securities held of record by Venrock Entrepreneurs Fund, L.P., a limited partnership of which Venrock Management LLC is the General Partner. Venrock Management LLC disclaims beneficial ownership of these securities except to the extent of its pro-rata interest.
- [F3]Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock automatically converted into 0.3559 shares of the Issuer's Common Stock.
- [F4]Not applicable.
Signature
Anthony B. Evnin, Member|2004-04-12